{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Financial Desk", "lead_paragraph": "LEAD: Amgen Inc.'s new drug for anemia, the latest biotechnology blockbuster, might set an industry record for first-year sales. Yet Amgen is shielded from competition by a law meant to encourage development of drugs for which there is supposed to be only a small market.", "headline": {"main": "Orphan Drug Law Spurs Debate"}, "abstract": null, "print_page": "1", "word_count": 1608, "_id": "4fd193be8eb7c8105d69e18a", "snippet": "LEAD: Amgen Inc.'s new drug for anemia, the latest biotechnology blockbuster, might set an industry record for first-year sales. Yet Amgen is shielded from competition by a law meant to encourage development of drugs for which there is supposed to be...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1990/04/30/business/orphan-drug-law-spurs-debate.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "ORPHAN DRUG ACT OF 1983"}, {"name": "subject", "value": "PRICES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "1990-04-30T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 1, "offset": 0, "time": 53}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}